Bone drug suppresses wandering tumor cells in breast cancer patients
Wednesday, June 2, 2010 - 14:51
in Health & Medicine
The bone-strengthening drug zoledronic acid (Zometa) can help fight metastatic breast cancer when given before surgery, suggests research at Washington University School of Medicine in St. Louis.